GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Nexwise Intelligence China
301248
5
Astro-century Education & Technology
300654
US Stock MarketDetailed Quotes
AVXL Anavex Life Sciences
- 10.200
- +0.210+2.10%
Close Jan 23 16:00 ET
- 10.200
- 0.0000.00%
Post 20:01 ET
865.12MMarket Cap-19.62P/E (TTM)
10.250High9.761Low1.14MVolume9.940Open9.990Pre Close11.50MTurnover1.39%Turnover RatioLossP/E (Static)84.82MShares14.44152wk High7.19P/B838.70MFloat Cap3.25052wk Low--Dividend TTM82.23MShs Float31.500Historical High--Div YieldTTM4.90%Amplitude0.600Historical Low10.046Avg Price1Lot Size
About Anavex Life Sciences Company
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Company Profile
SymbolAVXL
Company NameAnavex Life Sciences
Listing DateOct 28, 2015
Founded2004
CEODr. Christopher U. Missling, PhD
MarketNASDAQ
Employees42
Fiscal Year Ends09-30
Address630 5th Avenue,20th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10111
Phone1-844-689-3939
Websitehttp://www.anavex.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher U. Missling, PhD
- Director, President, Chief Executive Officer and Secretary
- 3.89M
- Sandra Boenisch, C.G.A.,C.P.A.
- Principal Financial Officer, Principal Accounting Officer and Treasurer
- 501.06K
- Dr. Jiong Ma, PhD
- Chairman of the Board
- 349.54K
- Dr. Peter Donhauser, D.O.
- Independent Director
- 341.54K
- Dr. Claus van der Velden, PhD
- Independent Director
- 357.54K
- Athanasios Skarpelos
- Independent Director
- 341.54K
- Dr. Steffen Thomas, PhD
- Independent Director
- 341.54K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline?
Moomoo News Global
Dec 9, 2024 20:23
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011